Global secretome analysis identifies novel mediators of bone metastasis.
about
Quantitative proteomics of the tobacco pollen tube secretome identifies novel pollen tube guidance proteins important for fertilization.Implications of Hypoxia in Breast Cancer Metastasis to BoneThe role of lysyl oxidase, the extracellular matrix and the pre-metastatic niche in bone metastasisFor robust big data analyses: a collection of 150 important pro-metastatic genesCavin-1/PTRF alters prostate cancer cell-derived extracellular vesicle content and internalization to attenuate extracellular vesicle-mediated osteoclastogenesis and osteoblast proliferation.Extracellular cystatin SN and cathepsin B prevent cellular senescence by inhibiting abnormal glycogen accumulation.Regulation of cancer metastasis by cell-free miRNAs.Proteomic characterization of epicardial-myocardial signaling reveals novel regulatory networks including a role for NF-κB in epicardial EMT.In vivo selection for spine-derived highly metastatic lung cancer cells is associated with increased migration, inflammation and decreased adhesion.Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patientsAn Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-SufficiencyControl of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasisExpression of COL6A1 predicts prognosis in cervical cancer patients.The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis.Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers.Challenges and opportunities for cell line secretomes in cancer proteomics.Lysyl Hydroxylase 2 Is Secreted by Tumor Cells and Can Modify Collagen in the Extracellular Space.Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion.Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme.Proteomic Analysis of Secreted Proteins from Cell Microenvironment.Identification of Nidogen 1 as a lung metastasis protein through secretome analysis.Quantifying critical states of complex diseases using single-sample dynamic network biomarkers.Reactive stroma component COL6A1 is upregulated in castration-resistant prostate cancer and promotes tumor growth.Procollagen Lysyl Hydroxylase 2 Expression Is Regulated by an Alternative Downstream Transforming Growth Factor β-1 Activation Mechanism.New secrets behind bone metastasis.Identification and validation of a prognostic 9-genes expression signature for gastric cancer.TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis.Biomarker Studies in Early Detection and Prognosis of Breast Cancer.The Ewing sarcoma secretome and its response to activation of Wnt/beta-catenin signaling.Regulation of breast cancer induced bone disease by cancer-specific IKKβ.Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas.
P2860
Q27336224-ECF39115-7689-47FB-A06D-6DE211162387Q28077444-95CF01DF-078B-45F2-B6C9-92DE058FE3D0Q28597660-34740AB1-E31A-46F0-9F9E-5CDB07A5C9D9Q31155755-D2988CAB-ABD6-4AE5-9623-BED4E6C902C5Q33813233-4C464A25-226B-4EDB-8630-CEF9ADECBEBAQ33815880-3A6C8EA6-FCD3-4E2F-BB0E-0CC026E0973DQ35034340-F647214F-695E-440E-A35F-11B56E3BBCC6Q36328527-92CED454-BF77-4EE4-B318-3523BAE97CDAQ36356108-7116CDB6-5AB4-4D21-A392-7B9829C0B061Q36413776-EBD0098B-67F3-4072-82B6-BE66476759C3Q36892847-D93F888E-D475-43B3-A3EA-1B1358D0D6CAQ36971430-9DA3C1B0-B22F-4565-96A5-C7EAB0AD726EQ37060813-29983A13-F5EC-471D-BBC1-7E08841DB9CCQ37126990-98311FAF-07F8-4CB9-9F1F-2B06063D880DQ37322289-EEF8B7ED-9D08-40DC-A9A8-62C9E0C53FF9Q37689678-456A4DAC-AB45-47C8-8E5C-742AF7F58618Q38270752-C82D75FC-FB39-4118-9A54-E6501FAE8C41Q38435130-D62D08E6-07E3-460E-A0A7-79078E5C0558Q38438782-3819184E-1237-48FE-AC14-F97096FA2E42Q38439155-095E83E3-FF79-4597-B28D-872C943ADCF2Q38598349-911A86CB-AADB-4A76-B142-518652C14B30Q38615448-3652E7B7-1605-4688-9CA0-62163CE570B3Q38662535-98E77D4F-8B29-460C-81FB-5DB6601E0A0BQ38884390-C8AD275D-C38D-4AE5-B137-78B8808B37B9Q42126549-AD898A5A-DA30-4541-A7D9-ECD8BF4EF351Q42323201-1E523F58-D902-4C84-9AAC-B5735B2A9419Q47240879-C1EB754A-C032-4788-99DB-2479FF00FFB1Q48293049-A3DA2738-87A9-471C-92F7-8E2A1272F002Q49544412-E6CC5ABE-8442-4435-AE50-7243C58A5564Q49546168-DF67A0D0-C940-462E-A3EF-2853994FBF89Q52584355-C9AABAB2-8E45-44FB-B402-4051ABABB3FFQ55365652-353FB3DB-B8E0-4055-B247-40B64408A246
P2860
Global secretome analysis identifies novel mediators of bone metastasis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Global secretome analysis identifies novel mediators of bone metastasis.
@ast
Global secretome analysis identifies novel mediators of bone metastasis.
@en
type
label
Global secretome analysis identifies novel mediators of bone metastasis.
@ast
Global secretome analysis identifies novel mediators of bone metastasis.
@en
prefLabel
Global secretome analysis identifies novel mediators of bone metastasis.
@ast
Global secretome analysis identifies novel mediators of bone metastasis.
@en
P2093
P2860
P356
P1433
P1476
Global secretome analysis identifies novel mediators of bone metastasis
@en
P2093
Benjamin A Garcia
Gary LeRoy
Mario Andres Blanco
Yibin Kang
P2860
P2888
P304
P356
10.1038/CR.2012.89
P577
2012-06-12T00:00:00Z